Loading...
NPI 1316966393 · Attleboro, MA · Pain Medicine (Anesthesiology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Do Chan is a pain medicine (anesthesiology) physician provider located in Attleboro, Massachusetts. This profile covers 25 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Do Chan |
| Address | 211 Park St |
| City | Attleboro |
| State | MA |
| ZIP | 02703 |
| Taxonomy | Pain Medicine (Anesthesiology) Physician |
| NPI Enumerated | July 19, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $369.8K |
| Medicaid | $56.1K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
25 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,320 | $90 | $118.5K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 480 | $150 | $72.2K |
| 62323 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the lumbar (lower back) or sacral (caudal, or tailbone)… | 400 | $140 | $54.1K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 540 | $60 | $32.2K |
| 27096 | The provider performs an injection in the joint between the sacrum and ilium on one side of the body, with the aid of imaging equipment to locate the injection site. He injects an anesthetic to… | 90 | $130 | $11.9K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 80 | $150 | $11.2K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 80 | $140 | $10.8K |
| 62321 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the cervical (neck) or thoracic (upper and middle back)… | 60 | $160 | $9.4K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 50 | $190 | $9.2K |
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 20 | $560 | $8.9K |
Showing 1–10 of 25
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
25 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 80307 | 16 | 130 | 120 | $60 | $36K |
| G0481 | 3 | 20 | 90 | $150 | $29.7K |
| G0482 | 13 | 20 | 60 | $190 | $20.9K |
| 64635 | 88 | 110 | 30 | $350 | $16.5K |
| 99214 | 79 | 15,410 | 110 | $80 | $15.6K |
| 64483 | 49 | 170 | 40 | $180 | $14.1K |
| 62323 | 4 | 190 | 70 | $120 | $12.2K |
| 64493 | 108 | 180 | 50 | $160 | $11.2K |
| 99215 | 4,016 | 6,360 | 40 | $120 | $8.9K |
| 64636 | 82 | 90 | 30 | $140 | $6K |
Showing 1–10 of 25
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 300 | $60 | $17.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 300 | $50 | $13.9K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 410 | $30 | $12.7K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 690 | $20 | $11.1K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 40 | $10 | $440 |
How this provider's Medicaid billing volume and revenue compare to other Massachusetts providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Massachusetts median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 167 | 370 | 500 | $40 | $605.1K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 30 | 40 | 990 | $70 | $257.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,155 | 5,040 | 200 | $70 | $209.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,415 | 5,300 | 230 | $60 | $164.5K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 104 | 130 | 270 | $1 | $4.4K |
Other providers in the same ZIP code as Do Chan, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Sturdy Memorial Hospital Inc | MA | General Acute Care Hospital | $0 | $53.7M |
| Kennedy Donovan Center, Inc | MA | Voluntary or Charitable Agency | $0 | $43.7M |
| Amego Inc. | MA | Community/Behavioral Health Agency | $0 | $33.9M |
| Uhs Of Fuller Inc | MA | Psychiatric Hospital | $0 | $13.5M |
| Hopehealth Hospice & Palliative Care | MA | Community Based Hospice Care Agency | $0 | $8.6M |
| New England Center For Psychiatric And Addiction Disorders, LLC | MA | Addiction Psychiatry Physician | $0 | $5.5M |
| City Of Attleboro | MA | Land Ambulance | $746.6K | $2.8M |
| Peter Fay | MA | Ophthalmology Physician | $357.4K | $0 |
| Kellyann Florentino | MA | Family Nurse Practitioner | $15.1K | $336.8K |
| Shields Sturdy Pet Ct LLC | MA | Mobile Radiology Clinic/Center | $321.4K | $22K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.